Pediatric leptomeningeal metastases: Outcome following combined therapy

Journal of Child Neurology

Volumn 12, Issue 1, 1997, Pages 53-59

  Chamberlain, Marc C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; METHOTREXATE; THIOTEPA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; EPENDYMOMA; FEMALE; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEPTOMENINX; MALE; METASTASIS; NEUROECTODERM TUMOR; NON SEMINOMATOUS GERMINOMA; NONHODGKIN LYMPHOMA; PINEAL BODY TUMOR; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031036005     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389701200109     Document Type: Article

References (34)

1. Chamberlain MC: A review of leptomeningeal metastasis in pediatrics. J Child Neurol 1995;10:191-199.
2. Bleyer WA: Biology and pathogenesis of CNS leukemia. Am J Pediatr Hematol Oncol 1989;11:57-63.
3. Bleyer WA, Byrne TN: Leptomeningeal cancer in leukemia and solid tumors. Curr Probl Cancer 1988;4:185-238.
4. Packer RJ, Siegel KR, Sutton LN, et al: Leptomeningeal dissemination of primary central nervous system tumors of childhood. Ann Neurol 1985;18:217-221.
5. Grossman S, Moynihan T: Neurologic complications of systemic cancer; Neoplastic meningitis. Neurol Clin 1991;9:843-856.
6. Recht L: Neurologic complications of systemic cancer, Neurologic complications of systemic lymphoma. Neurol Clin 1991;9:1001-1015.
7. Walker R: Neurologic complications of systemic cancer; Neurologic complications of leukemia. Neurol Clin 1991;9:989-999.
8. Stanley P, Senac MO Jr, Segall HD: Intraspinal seeding from intracranial tumors in children. AJNR Am J Neuroradiol 1984;5:805-809.
9. Kandt RS, Shinnar S, D'Souza BJ, et al: Cerebrospinal metastases in malignant childhood astrocytomas. J Neurooncol 1984;2:123-128.
10. Civitello LA, Packer RJ, Rorke LB, et al: Leptomeningeal dissemination of low-grade gliomas in childhood. Neurology 1988;38:562-566.
11. Grabb PA, Albright AL, Pang D: Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery 1992;30:64-71.
12. Wallner K, Wara WM, Sheline G, Davis R: Intracranial ependymomas: Results of treatment with partial or whole brain irradiation without spinal irradiation. Int J Radiat Oncol Biol Phys 1983;12:1937-1941.
13. Linstadt D, Wara W, Edwards M, et al: Radiotherapy of primary intracranial germinomas: The case against routine craniospinal irradiation. Int J Radiat Oncol Biol Phys 1988;15:291-297.
14. Chamberlain MC, Dirr L: Involved field radiotherapy and Intra-Ommaya methotrexate/ara-C in patients with AIDS-related lymphomatous meningitis. J Clin Oncol 1993;11:1978-1993.
15. Balls F, Poplack D: Central nervous system pharmacology of antileukemic drugs. Am J Pediatr Hematol Oncol 1989;11:74-86.
16. Collins J: Pharmacokinetics of intraventricular administration. J Neurooncol 1983;1:283-291.
17. Fulton D, Levin V, Gutin P, et al: Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors. Cancer Chemother Pharmacol 1982;8:286-291.
18. Gutin P, Weiss H, Wiernik P, Walker M: Intrathecal N, N', N"-triethylenethiophosphoramide [thio-TEPA (NSC 6369)] in the treatment of malignant meningeal disease; Phase I-II Study. Cancer 1976;38:1471-1475.
19. Gutin P, Levi J, Wiernik P, Walker M: Treatment of malignant meningeal disease with intrathecal thio-TEPA. A Phase II Study. Cancer Treat Reporte 1977;61:885-887.
20. Strong J, Collins J, Lester C, Poplack D: Pharmacokinetics of intraventricular and intravenous N, N', N"-triethylenethiophosphoramide (Thiotepa) in rhesus monkeys and humans. Cancer Res 1986;46:6101-6104.
21. Chamberlain MC, Sandy A, Press GA: Leptomeningeal metastasis: A comparison of gadolinium-enhanced MR and contras-tenhanced CT of the brain, Neurology 1990;40:435-438.
22. Chamberlain MC: Comparative spine imaging in leptomeningeal metastases. J Neurooncol 1995;23:233-238.
23. Kramer E, Rafto S, Packer R, Zirnmerman R: Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children. Neurology 1991;41:46-50.
24. Rippe D, Boyko O, Friedman H, et al: Gd-DTPA-enhanced MR imaging of leptomeningeal spread of primary CNS tumor in children. AJNR Am J Neuroradiol 1990;11:329-332.
25. Chamberlain MC, Corey-Bloom J: Leptomeningeal metastasis: Indium-DTPA CSF flow studies. Neurology 1991;41:1765-1769.
26. 111In-DTPA cerebrospinal fluid flow studies. J Child Neurol 1994;9:150-154.
27. Grossman SA, Trump DL, Chen DCP, et al: Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. Am J Med 1982;73:641-647.
28. Slevin M, Piall E, Aherne G, et al: Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. J Clin Oncol 1983;1:546-551.
29. Lopez J, Nassif E, Vannicola P, et al: Central nervous system pharmacokinetics of high-dose cytosine arabinoside. J Neurooncol 1985;3:119-124.
30. Ackland S, Schilsky R: Review article: High-dose methotrexate: A critical reappraisal. J Clin Oncol 1987;5:2017-2031.
31. Lishner M, Perrin R, Feld R, et al: Complications associated with Ommaya reservoirs in patients with cancer. Arch Intern Med 1990;150:173-176.
32. Blasberg R, Patlak C, Fenstermacher J: Intrathecal chemotherapy brain tissue profiles after ventriculo-cisternal perfusion. Pharm Exp Ther 1975;195:73-83.
33. Shapiro WR, Young DF, Mehta BM: Methotrexate distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. New Engl J Med 1975;293:161-166.
34. Kim S, Chatelut E, Kim JC, et al: Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol 1993;11:2186-2193.